Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Persistent Corneal Epithelial Defect · Corneal Epithelial Disorders

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Illinois at Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Jale Yucel) · zjyucel@uic.edu · 708-752-6905

Study leads

Ali R Djalilian, MD
Principal Investigator
University of Illinois at Chicago

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Persistent Corneal Epithelial Defect

Abroad (travel likely)RecruitingPHASE2

Dothan, United States · Petaluma, United States

An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

Persistent Corneal Epithelial Defect

Abroad (travel likely)RecruitingPHASE3

Huntington Beach, United States · Laguna Hills, United States

Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects

Persistent Corneal Epithelial Defect

Abroad (travel likely)RecruitingPHASE4

Rawalpindi, Pakistan